Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Other Working Capital Changes (2025)

Updated

Drugs Made In America Acquisition's Other Working Capital Changes was -$21,425 in Q4 2025.

Analysis

Drugs Made In America Acquisition (DMAA) Other Working Capital Changes (2025) Analysis & Trends

For FY2025, Other Working Capital Changes at Drugs Made In America Acquisition came in at $6,054.

  • Quarterly Other Working Capital Changes has moved between -$21,425 (Q3 2025) and $70,096 (Q1 2025) over five years.
  • Per Business Quant data, DMAA's Other Working Capital Changes in the three quarters before Q4 2025 was -$21,425 (Q3 2025), -$21,192 (Q2 2025) and $70,096 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 BlackRock 165.40 Bn 111.76 Bn -
2 Spdr Gold Trust 133.61 Bn -424.39 Bn -
3 Blackstone 84.03 Bn 78.95 Bn -
4 Brookfield 82.79 Bn -82.59 Bn 4.47 Bn
5 Kkr 80.75 Bn 47.23 Bn -
6 Brookfield Asset Management 71.44 Bn 67.69 Bn -
7 Apollo Global Management 66.43 Bn 4.11 Bn 10.56 Bn
8 Wheaton Precious Metals 61.87 Bn 57.29 Bn 687.86 Mn
9 Franco Nevada 46.42 Bn 43.78 Bn 451.00 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -21,425.00
Sep 30, 2025 -21,425.00
Jun 30, 2025 -21,192.00
Mar 31, 2025 70,096.00
API Access

Drugs Made In America Acquisition Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=DMAA&period=max&api_key=YOUR_API_KEY